Patent · US Active

Substituted pyrimidines useful as protein kinase inhibitors

US7557106B2 · kind B2 · utility

41Cited by
57References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2006
Grant dateJul 7, 2009
Priority date
Expiry dateFeb 2, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D453/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a facile process for the preparation of tri- and tetra-substituted pyrimidines. The process is useful for preparing inhibitors of protein kinases, especially Aurora kinase. These inhibitors are useful for treating or lessening the severity of Aurora-mediated diseases or conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.